Citation: H. White et al., ALT IS NO LONGER AN APPROPRIATE EFFICACY END-POINT TO ASSESS THERAPIES FOR CHRONIC HCV, Hepatology, 28(4), 1998, pp. 2164-2164
Authors:
BALART L
ROSENBLATE H
HOEFS J
POCKROS P
ALBERT D
Citation: L. Balart et al., PATIENTS WHO RELAPSE DO SO EARLY AFTER INTERFERON TREATMENT BUT BENEFIT BY REDUCED HCV RNA CONCENTRATIONS, Hepatology, 28(4), 1998, pp. 2210-2210
Authors:
BEUTLER E
GELBART T
WEST C
LEE P
ADAMS M
BLACKSTONE R
POCKROS P
KOSTY M
VENDITTI CP
PHATAK PD
SEESE NK
CHORNEY KA
TENELSHOF AE
GERHARD GS
CHORNEY M
Citation: E. Beutler et al., MUTATION ANALYSIS IN HEREDITARY HEMOCHROMATOSIS, Blood cells, molecules, & diseases, 22(16), 1996, pp. 187-194
Authors:
BEUTLER E
GELBART T
WEST C
LEE P
ADAMS M
BLACKSTONE R
POCKROS P
KOSTY M
VENDITTI CP
PHATAK PD
SEESE NK
CHORNEY KA
TENELSHOF AE
GERHARD GS
CHORNEY M
Citation: E. Beutler et al., MUTATION ANALYSIS IN HEREDITARY HEMOCHROMATOSIS (CORRECTED VERSION OFVF214), Blood cells, molecules, & diseases, 22(16), 1996, pp. 187-194
Authors:
HOLLINGER FB
BLATT LM
TONG MJ
CONRAD A
BALART L
POCKROS P
BONKOVSKY HL
EHRINPREIS MN
LUBINA J
Citation: Fb. Hollinger et al., DIFFERENTIAL RESPONSE TO TREATMENT WITH CONSENSUS INTERFERON (CIFN) AND IFN-ALPHA 2B IN CHRONIC HCV PATIENTS INFECTED WITH GENOTYPE 1A AND 1B, Gastroenterology, 110(4), 1996, pp. 1213-1213